Last updated: July 23, 2024
Sponsor: Western University, Canada
Overall Status: Active - Recruiting
Phase
N/A
Condition
Liver Cancer
Kidney Cancer
Urothelial Tract Cancer
Treatment
Biopsy
Ablation
Clinical Study ID
NCT03844399
6319
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- • Patients who are scheduled for standard care liver or kidney ablation or biopsy
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: Biopsy
Phase:
Study Start date:
October 03, 2020
Estimated Completion Date:
September 30, 2025
Study Description
Connect with a study center
Victoria Hospital
London, Ontario N6A 5W9
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.